U.S. flag

An official website of the United States government

NM_000463.3(UGT1A1):c.1198A>G (p.Asn400Asp) AND UGT1A1-related disorder

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 21, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004528106.1

Allele description [Variation Report for NM_000463.3(UGT1A1):c.1198A>G (p.Asn400Asp)]

NM_000463.3(UGT1A1):c.1198A>G (p.Asn400Asp)

Genes:
  • UGT1A:UDP glucuronosyltransferase family 1 member A complex locus [Gene - HGNC]
  • UGT1A10:UDP glucuronosyltransferase family 1 member A10 [Gene - OMIM - HGNC]
  • UGT1A1:UDP glucuronosyltransferase family 1 member A1 [Gene - OMIM - HGNC]
  • UGT1A3:UDP glucuronosyltransferase family 1 member A3 [Gene - OMIM - HGNC]
  • UGT1A4:UDP glucuronosyltransferase family 1 member A4 [Gene - OMIM - HGNC]
  • UGT1A5:UDP glucuronosyltransferase family 1 member A5 [Gene - OMIM - HGNC]
  • UGT1A6:UDP glucuronosyltransferase family 1 member A6 [Gene - OMIM - HGNC]
  • UGT1A7:UDP glucuronosyltransferase family 1 member A7 [Gene - OMIM - HGNC]
  • UGT1A8:UDP glucuronosyltransferase family 1 member A8 [Gene - OMIM - HGNC]
  • UGT1A9:UDP glucuronosyltransferase family 1 member A9 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q37.1
Genomic location:
Preferred name:
NM_000463.3(UGT1A1):c.1198A>G (p.Asn400Asp)
HGVS:
  • NC_000002.12:g.233768333A>G
  • NG_002601.2:g.183590A>G
  • NG_033238.1:g.13061A>G
  • NM_000463.3:c.1198A>GMANE SELECT
  • NM_001072.4:c.1195A>GMANE SELECT
  • NM_007120.3:c.1201A>GMANE SELECT
  • NM_019075.4:c.1189A>GMANE SELECT
  • NM_019076.5:c.1189A>GMANE SELECT
  • NM_019077.3:c.1189A>GMANE SELECT
  • NM_019078.2:c.1201A>GMANE SELECT
  • NM_019093.4:c.1201A>GMANE SELECT
  • NM_021027.3:c.1189A>GMANE SELECT
  • NM_205862.3:c.394A>G
  • NP_000454.1:p.Asn400Asp
  • NP_000454.1:p.Asn400Asp
  • NP_001063.2:p.Asn399Asp
  • NP_001063.2:p.Asn399Asp
  • NP_009051.1:p.Asn401Asp
  • NP_009051.1:p.Asn401Asp
  • NP_061948.1:p.Asn397Asp
  • NP_061948.1:p.Asn397Asp
  • NP_061949.3:p.Asn397Asp
  • NP_061949.3:p.Asn397Asp
  • NP_061950.2:p.Asn397Asp
  • NP_061950.2:p.Asn397Asp
  • NP_061951.1:p.Asn401Asp
  • NP_061951.1:p.Asn401Asp
  • NP_061966.1:p.Asn401Asp
  • NP_061966.1:p.Asn401Asp
  • NP_066307.1:p.Asn397Asp
  • NP_066307.1:p.Asn397Asp
  • NP_995584.1:p.Asn132Asp
  • NP_995584.1:p.Asn132Asp
  • LRG_733t1:c.1198A>G
  • LRG_733:g.13061A>G
  • LRG_733p1:p.Asn400Asp
  • NC_000002.11:g.234676979A>G
  • NM_000463.2:c.1198A>G
  • NM_001072.3:c.1195A>G
  • NM_007120.2:c.1201A>G
  • NM_019075.2:c.1189A>G
  • NM_019076.4:c.1189A>G
  • NM_019077.2:c.1189A>G
  • NM_019078.1:c.1201A>G
  • NM_019093.2:c.1201A>G
  • NM_021027.2:c.1189A>G
  • NM_205862.1:c.394A>G
  • P22309:p.Asn400Asp
Protein change:
N132D; ASN400ASP
Links:
UniProtKB: P22309#VAR_019412; OMIM: 191740.0022; dbSNP: rs28934877
NCBI 1000 Genomes Browser:
rs28934877
Molecular consequence:
  • NM_000463.3:c.1198A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001072.4:c.1195A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_007120.3:c.1201A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_019075.4:c.1189A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_019076.5:c.1189A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_019077.3:c.1189A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_019078.2:c.1201A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_019093.4:c.1201A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_021027.3:c.1189A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_205862.3:c.394A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
UGT1A1-related disorder
Synonyms:
UGT1A1-Related Disorders; UGT1A1-related condition
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000915898Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 09 May 2019)
Uncertain significance
(Nov 21, 2018)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

PharmGKB summary: very important pharmacogene information for UGT1A1.

Barbarino JM, Haidar CE, Klein TE, Altman RB.

Pharmacogenet Genomics. 2014 Mar;24(3):177-83. doi: 10.1097/FPC.0000000000000024. Review. No abstract available.

PubMed [citation]
PMID:
24492252
PMCID:
PMC4091838

Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.

Labrune P, Myara A, Chalas J, Le Bihan B, Capel L, Francoual J.

Hum Mutat. 2002 Nov;20(5):399-401. No abstract available.

PubMed [citation]
PMID:
12402338

Details of each submission

From Illumina Laboratory Services, Illumina, SCV000915898.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

The UGT1A1 c.1198A>G (p.Asn400Asp) missense variant has been reported in one study and is found in a total of three patients including one in a homozygous state with Crigler-Najjar syndrome type II (CN-II) and two in a heterozygous state with Gilbert syndrome (Labrune et al. 2002). The patient with CN-II carried a second homozygous variant in the TATA box promoter region identified as UGT1A1*37. The p.Asn400Asp variant was absent from 50 control chromosomes and is reported at a frequency of 0.00007 in the European (non-Finnish) population of the Exome Aggregation Consortium. Based on the limited evidence, the p.Asn400Asp variant is classified as a variant of unknown significance but suspicious for pathogenicity for UGT1A1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024